ArticleBMJ public health2025

What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK.

Nadja Auerbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.